Evidence map›Paper›PMID 28871006›Full record

ArticleCancer genomics & proteomics

Post-transcriptional Regulation of MMP16 and TIMP2 Expression

Beata Rak, Dawid Mehlich, Filip Garbicz, Zofia Domosud, Wiktor Paskal, Janina M Marczewska, Paweł K Włodarski

Open access · diamondAbstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Analysis of miRNAs inPharmaceuticals (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Review
  6. Article
  7. Metalloproteinases in Endometrial Cancer-Are They Worth Measuring?International journal of molecular sciences · 2021
    Review
  8. Article
  9. CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Beata RakDepartment of Histology and Embryology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Dawid MehlichDepartment of Histology and Embryology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Filip GarbiczDepartment of Histology and Embryology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Zofia DomosudDepartment of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Wiktor PaskalDepartment of Histology and Embryology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Janina M MarczewskaDepartment of Pathology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
Paweł K WłodarskiDepartment of Histology and Embryology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland pawel.wlodarski@wum.edu.pl.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe post-transcriptional regulation of matrix metalloproteinases (MMPs) via microRNAs (miRNAs) has been recently described in numerous human malignancies. However, the exact mechanisms of miRNA-mediated MMPs deregulation in endometrial cancer (EC) remain unclear. Herein, we aimed to analyze the expression of MMP2, MMP16 and TIMP2 and identify miRNAs that modulate their expression. MATERIALS AND

methodsProtein expression was assessed by immunohistochemistry in formalin-fixed paraffin-embedded EC samples. Target prediction algorithms were applied to select miRNAs binding the 3'UTRs of MMP16 (miR-377, miR-382, miR-410, miR-200b) or TIMP2 (miR-200b), and their levels were measured by qPCR in laser capture-microdissected tissue fragments. Luciferase assays and western blotting were used to indicate individual miRNA- mRNA interactions.

resultsOverexpression of MMP2 and MMP16 in cancerous tissues corresponded to down-regulation of miR-377, miR-382 and miR-410, while decreased expression of TIMP2 was associated with miR-200b up-regulation. In vitro experiments confirmed direct regulation of MMP16 by miR-382 and miR-410, and TIMP2 by miR-200b in EC Ishikawa cells.

conclusionWe demonstrated novel mechanisms of miRNA-mediated regulation of MMPs activity in EC.

Indexed as

Gene Expression Regulation, NeoplasticTranscription, Genetic3' Untranslated RegionsBase SequenceCell Line, TumorDown-RegulationEndometrial NeoplasmsFemaleHEK293 CellsHumansImmunohistochemistryLaser Capture MicrodissectionMatrix Metalloproteinase 16Matrix Metalloproteinase 2MicroRNAsTissue Inhibitor of Metalloproteinase-23' Untranslated RegionsMatrix Metalloproteinase 16Matrix Metalloproteinase 2MicroRNAsMIRN200 microRNA, humanMIRN382 microRNA, humanMIRN410 microRNA, humanMMP16 protein, humanTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2Endometrial cancermicroRNAsMMP16MMP2TIMP2

Identifiers

PMID28871006
PMCPMC5611525
OpenAlexW2752581362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.